BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26667212)

  • 1. Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
    McGinley KF; Sun X; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ
    Int J Urol; 2016 Mar; 23(3):241-6. PubMed ID: 26667212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE.
    Berglund RK; Sadetsky N; DuChane J; Carroll PR; Klein EA
    J Urol; 2007 Feb; 177(2):526-29; discussion 529-30. PubMed ID: 17222625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases.
    Feicke A; Baumgartner M; Talimi S; Schmid DM; Seifert HH; Müntener M; Fatzer M; Sulser T; Strebel RT
    Eur Urol; 2009 Apr; 55(4):876-83. PubMed ID: 19101076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inguinal hernia after radical retropubic prostatectomy for prostate cancer: a study of incidence and risk factors in comparison to no operation and lymphadenectomy.
    Lodding P; Bergdahl C; Nyberg M; Pileblad E; Stranne J; Hugosson J
    J Urol; 2001 Sep; 166(3):964-7. PubMed ID: 11490256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.
    Kawakami J; Meng MV; Sadetsky N; Latini DM; Duchane J; Carroll PR;
    J Urol; 2006 Oct; 176(4 Pt 1):1382-6. PubMed ID: 16952638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic pelvic lymph node dissection, laparoscopically assisted seminal vesicle mobilization, and total perineal prostatectomy versus radical retropubic prostatectomy for prostate cancer.
    Teichman JM; Reddy PK; Hulbert JC
    Urology; 1995 May; 45(5):823-30. PubMed ID: 7538244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-stage laparoscopic pelvic lymphadenectomy and radical perineal prostatectomy.
    Thomas R; Steele R; Smith R; Brannan W
    J Urol; 1994 Oct; 152(4):1174-7. PubMed ID: 8072087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy.
    Prasad SM; Keating NL; Wang Q; Pashos CL; Lipsitz S; Richie JP; Hu JC
    Urology; 2008 Sep; 72(3):647-52; discussion 652-3. PubMed ID: 18649928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
    Stock RG; Stone NN; Ianuzzi C; Unger P
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
    Briganti A; Karakiewicz PI; Chun FK; Gallina A; Salonia A; Zanni G; Valiquette L; Graefen M; Huland H; Rigatti P; Montorsi F
    Eur Urol; 2007 Jun; 51(6):1573-81. PubMed ID: 17293026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
    Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
    Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE
    Eur Urol; 2006 Aug; 50(2):272-9. PubMed ID: 16632187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era.
    Goto Y; Utsumi T; Maruo M; Kurozumi A; Noro T; Tanaka S; Sugawara S; Chiba K; Miyazaki K; Inoue A; Komaru A; Fukasawa S; Imamura Y; Sakamoto S; Nakatsu H; Suzuki H; Ichikawa T; Nagata M
    Int J Urol; 2023 Aug; 30(8):659-665. PubMed ID: 37130793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended pelvic lymph node dissection in robot-assisted radical prostatectomy is an independent risk factor for major complications.
    Baas DJH; de Baaij JMS; Sedelaar JPM; Hoekstra RJ; Vrijhof HJEJ; Somford DM; van Basten JA
    J Robot Surg; 2024 Mar; 18(1):140. PubMed ID: 38554195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended pelvic lymph node dissection during robotic prostatectomy: antegrade versus retrograde technique.
    Albo G; Gallioli A; Ripa F; De Lorenzis E; Boeri L; Bebi C; Rocchini L; Longo F; Zanetti SP; Turetti M; Piccoli M; Montanari E
    BMC Urol; 2024 Mar; 24(1):64. PubMed ID: 38515053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictors of pelvic lymph node metastasis at radical retropubic prostatectomy.
    Naya Y; Babaian RJ
    J Urol; 2003 Dec; 170(6 Pt 1):2306-10. PubMed ID: 14634402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of laparoscopic lymphadenectomy in conjunction with radical perineal or retropubic prostatectomy.
    Parra RO; Boullier JA; Rauscher JA; Cummings JM
    J Urol; 1994 Jun; 151(6):1599-602. PubMed ID: 8189572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.